BR112016025876A8 - composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2 - Google Patents
composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2Info
- Publication number
- BR112016025876A8 BR112016025876A8 BR112016025876A BR112016025876A BR112016025876A8 BR 112016025876 A8 BR112016025876 A8 BR 112016025876A8 BR 112016025876 A BR112016025876 A BR 112016025876A BR 112016025876 A BR112016025876 A BR 112016025876A BR 112016025876 A8 BR112016025876 A8 BR 112016025876A8
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- microcapsule
- dosage form
- unit dosage
- vitamin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 239000003094 microcapsule Substances 0.000 title abstract 5
- 239000002552 dosage form Substances 0.000 title abstract 4
- 239000000047 product Substances 0.000 title abstract 2
- 229940088594 vitamin Drugs 0.000 title abstract 2
- 229930003231 vitamin Natural products 0.000 title abstract 2
- 235000013343 vitamin Nutrition 0.000 title abstract 2
- 239000011782 vitamin Substances 0.000 title abstract 2
- 150000003722 vitamin derivatives Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 229940046010 vitamin k Drugs 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000416 hydrocolloid Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/20—Ingredients acting on or related to the structure
- A23V2200/224—Encapsulating agent
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/714—Vitamin K
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Physiology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2 a invenção se refere a uma composição compreendendo a) microcápsulas compreendendo pelo menos uma substância ativa lipossolúvel selecionada de um composto de vitamina k ou uma provitamina ou uma pró-droga de um composto de vitamina k embutido em uma matriz que compreende um hidrocoloide e opcionalmente um ou mais outros componentes de matriz, e b) pelo menos um mineral alimentar; assim como usos e produtos compreendendo tais composições.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14166967.1 | 2014-05-05 | ||
EP14166967 | 2014-05-05 | ||
PCT/EP2015/059884 WO2015169816A1 (en) | 2014-05-05 | 2015-05-05 | Formulation of fat-soluble vitamin |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112016025876A2 BR112016025876A2 (pt) | 2017-08-15 |
BR112016025876A8 true BR112016025876A8 (pt) | 2021-07-06 |
BR112016025876B1 BR112016025876B1 (pt) | 2023-03-14 |
Family
ID=50677999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016025876-2A BR112016025876B1 (pt) | 2014-05-05 | 2015-05-05 | Composição, processo para preparar uma composição, e, produto |
Country Status (12)
Country | Link |
---|---|
US (1) | US11090276B2 (pt) |
EP (1) | EP3139904B1 (pt) |
JP (1) | JP6811614B2 (pt) |
KR (1) | KR102500913B1 (pt) |
CN (2) | CN114982971A (pt) |
AU (1) | AU2015257786B2 (pt) |
BR (1) | BR112016025876B1 (pt) |
DK (1) | DK3139904T3 (pt) |
ES (1) | ES2863048T3 (pt) |
MX (1) | MX2016014509A (pt) |
PL (1) | PL3139904T3 (pt) |
WO (1) | WO2015169816A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3139904B1 (en) | 2014-05-05 | 2021-03-03 | Basf Se | Formulation of fat-soluble vitamin |
PE20200663A1 (es) * | 2017-08-25 | 2020-06-11 | Dsm Ip Assets Bv | Nueva formulacion |
KR20200093608A (ko) * | 2017-11-27 | 2020-08-05 | 디에스엠 아이피 어셋츠 비.브이. | 냉동-건조된 다중미립자 고체 투여 형태 |
US20220127652A1 (en) * | 2019-07-02 | 2022-04-28 | Sungen Bioscience Co., Ltd. | Bacillus subtilis natto and method for producing protein mk-7 |
KR20230026494A (ko) | 2020-06-23 | 2023-02-24 | 디에스엠 아이피 어셋츠 비.브이. | 발효 방법 |
WO2022061870A1 (zh) * | 2020-09-28 | 2022-03-31 | 厦门金达威生物科技有限公司 | 维生素k2微胶囊及其制备方法和在制备防治心脑血管疾病的药物中的应用 |
CN112655968A (zh) * | 2020-12-15 | 2021-04-16 | 南通励成生物工程有限公司 | 一种高稳定性维生素k2粉末及其制备方法 |
US20220193154A1 (en) * | 2020-12-23 | 2022-06-23 | Preoperative Nutrition | Preoperative compositions and methods of preparation thereof |
US20220193156A1 (en) * | 2020-12-23 | 2022-06-23 | Thi Tuyet Mai Ta | Preoperative compositions and methods of preparation thereof |
GB2608393A (en) | 2021-06-29 | 2023-01-04 | Kappa Bioscience As | Vitamin K2 compositions |
WO2023232643A1 (en) | 2022-05-31 | 2023-12-07 | Region Syddanmark | Vitamin k2 for use in treatment of coronary artery calcification |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6365945A (ja) * | 1986-09-05 | 1988-03-24 | Eisai Co Ltd | マイクロカプセルの製造方法 |
DK546289D0 (da) | 1989-11-02 | 1989-11-02 | Danochemo As | Carotenoidpulvere |
DE19642359A1 (de) | 1996-10-14 | 1998-04-16 | Basf Ag | Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung |
DE19838189A1 (de) | 1998-08-24 | 2000-03-02 | Basf Ag | Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung |
DK1106174T4 (en) | 1999-12-09 | 2017-01-23 | Dsm Ip Assets Bv | Compositions containing fat-soluble vitamins |
PT1153548E (pt) | 2000-05-12 | 2007-08-08 | Nattopharma Asa | Produto alimentar contendo vitamina k |
ATE326866T1 (de) | 2002-10-17 | 2006-06-15 | Suedzucker Ag | Verfahren zur herstellung einer isomaltulose- haltigen enteralnahrung |
US8252322B2 (en) | 2003-06-03 | 2012-08-28 | Corn Products Development, Inc. | Delivery system with increased bioavailability |
NO320546B1 (no) | 2003-12-12 | 2005-12-19 | Nova Biotics As | Prebiotiske kombinasjonsprodukter |
US20070275081A1 (en) * | 2004-02-06 | 2007-11-29 | Hansen Carsten L | Aqueous Dispersion and Its Use |
US20050186307A1 (en) * | 2004-02-20 | 2005-08-25 | Axelrod Glen S. | Pet food with enhanced nutritional value |
JP2006320311A (ja) * | 2005-04-19 | 2006-11-30 | Nisshin Pharma Inc | コエンザイムq10およびミネラル類を含有する食品並びにその製造方法 |
EP1937287B1 (en) | 2005-10-11 | 2012-02-29 | Bayer Consumer Care AG | Mixture of iron and copper salts masking metallic taste |
PL1940249T3 (pl) * | 2005-10-21 | 2015-11-30 | Dsm Ip Assets Bv | Nowe formulacje rozpuszczalnych w tłuszczach składników aktywnych o wysokiej biodostępności |
ES2632132T5 (es) | 2007-12-21 | 2021-12-27 | Basf Se | Microcápsulas que comprenden una sustancia activa soluble en grasa |
NL1034964C2 (nl) * | 2008-01-28 | 2009-07-30 | Friesland Brands Bv | Werkwijze en composities voor de behandeling van botaandoeningen. |
GB0817528D0 (en) | 2008-09-24 | 2008-10-29 | Syntavit As | Process |
CN101401809B (zh) * | 2008-11-12 | 2011-07-20 | 杭州赛诺菲民生健康药业有限公司 | 一种维生素和矿物质组合物的制备工艺 |
CN101422446B (zh) * | 2008-12-18 | 2010-06-09 | 浙江大学 | 一种维生素k微胶囊的制备方法 |
WO2011152810A1 (en) | 2010-06-03 | 2011-12-08 | Bilgic Mahmut | Formulations comprising calcium, vitamin d and vitamin k for osteoporosis |
CN102318835B (zh) * | 2011-08-31 | 2013-01-09 | 石家庄中硕药业集团有限公司 | 一种减少骨质流失的组合物及其制备方法 |
CA2851566C (en) * | 2011-10-14 | 2020-01-14 | Dsm Ip Assets B.V. | Novel coating system |
GB201203705D0 (en) | 2012-03-02 | 2012-04-18 | Kappa Bioscience As | Prodrugs |
CN104619187A (zh) * | 2012-04-12 | 2015-05-13 | Idcaps公司 | 含有可氧化的活性物的微胶囊,和制备其的方法 |
CN102716087B (zh) * | 2012-05-31 | 2014-06-11 | 浙江中同科技有限公司 | 一种维生素粉末及其制备方法 |
BR112015003399A2 (pt) | 2012-08-14 | 2017-07-04 | Abbott Lab | métodos e composições úteis para melhorar a saúde óssea e articular |
EP3139904B1 (en) | 2014-05-05 | 2021-03-03 | Basf Se | Formulation of fat-soluble vitamin |
-
2015
- 2015-05-05 EP EP15719484.6A patent/EP3139904B1/en active Active
- 2015-05-05 CN CN202210659038.4A patent/CN114982971A/zh active Pending
- 2015-05-05 CN CN201580031823.3A patent/CN106455667A/zh active Pending
- 2015-05-05 BR BR112016025876-2A patent/BR112016025876B1/pt active IP Right Grant
- 2015-05-05 DK DK15719484.6T patent/DK3139904T3/da active
- 2015-05-05 MX MX2016014509A patent/MX2016014509A/es unknown
- 2015-05-05 WO PCT/EP2015/059884 patent/WO2015169816A1/en active Application Filing
- 2015-05-05 ES ES15719484T patent/ES2863048T3/es active Active
- 2015-05-05 US US15/308,926 patent/US11090276B2/en active Active
- 2015-05-05 AU AU2015257786A patent/AU2015257786B2/en active Active
- 2015-05-05 PL PL15719484T patent/PL3139904T3/pl unknown
- 2015-05-05 JP JP2016566638A patent/JP6811614B2/ja active Active
- 2015-05-05 KR KR1020167034074A patent/KR102500913B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
MX2016014509A (es) | 2017-02-23 |
US20170056339A1 (en) | 2017-03-02 |
AU2015257786B2 (en) | 2020-04-30 |
PL3139904T3 (pl) | 2021-07-05 |
US11090276B2 (en) | 2021-08-17 |
AU2015257786A1 (en) | 2016-12-15 |
JP2017521359A (ja) | 2017-08-03 |
CN106455667A (zh) | 2017-02-22 |
EP3139904A1 (en) | 2017-03-15 |
EP3139904B1 (en) | 2021-03-03 |
KR20160148028A (ko) | 2016-12-23 |
BR112016025876A2 (pt) | 2017-08-15 |
ES2863048T3 (es) | 2021-10-08 |
WO2015169816A1 (en) | 2015-11-12 |
BR112016025876B1 (pt) | 2023-03-14 |
CN114982971A (zh) | 2022-09-02 |
KR102500913B1 (ko) | 2023-02-16 |
DK3139904T3 (da) | 2021-03-29 |
JP6811614B2 (ja) | 2021-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016025876A8 (pt) | composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2 | |
BR112017022604A2 (pt) | composto, composição farmacêutica, uso de um composto e de uma combinação, e, combinação | |
MX2018004175A (es) | Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas. | |
CL2019001369A1 (es) | Composición farmacéutica para prevenir o tratar el cáncer de mama, incluido el polimorfo cristalino del hexoxido tetraarsenico y el método para producirlo. | |
BR112017028318A2 (pt) | compostos antibacterianos | |
DOP2016000226A (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
CL2020000632A1 (es) | Composición y método para el tratamiento del autismo. | |
BR112017003346B8 (pt) | Derivados de pirazolopiridina, seus usos, e composição farmacêutica | |
CL2015001772A1 (es) | Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma. | |
CO2017007325A2 (es) | 2,4 diamino-quinolina sustituida como nuevos agentes anti-cancerigenos | |
BR112018003745A2 (pt) | composições que compreendem um composto de urolitina | |
CL2015000039A1 (es) | Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis. | |
CR20140144A (es) | Derivados de estra-1,3,5 (10), 16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos | |
DOP2016000212A (es) | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados | |
SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
BR112018006730A2 (pt) | método para preparar um composto, substância ou mistura de substância, uso de pelo menos uma substância ou mistura de substância, composição de fragrância, e, agente. | |
NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
BR112017019750A2 (pt) | processo para preparação de uma forma cristalina de menaquinol, forma cristalina de menaquinol, processo para preparação de uma forma sólida do menaquinol, composição farmacêutica ou nutracêutica e uso da forma cristalina de menaquinol | |
UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
CO2017002813A2 (es) | Derivados estabilizados de adrenomedulina y uso de los mismos | |
BR112017022523A2 (pt) | ?formulação para cápsulas de gel, cápsula de gel, e, processo?. | |
BR112018011476A2 (pt) | formulação de vitamina | |
BR112018008588A2 (pt) | composição, e, processo para preparar uma composição. | |
BR112017020053A2 (pt) | novo composto heterocíclico, método para a preparação do mesmo e composição farmacêutica compreendendo o mesmo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 9/16 (2006.01), A61K 9/20 (2006.01), A61K 9/5 |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/05/2015, OBSERVADAS AS CONDICOES LEGAIS |